MedTrace Logo

Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors

NCT01510730 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 855

Last updated 2012-03-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether Helicobacter pylori eradication could reduce the new tumor development after endoscopic resection of gastric tumor.

Conditions

  • Gastric Tumor
  • Helicobacter Pylori
  • Endoscopic Resection
  • Metachronous Neoplasms

Interventions

DRUG

eradication treatment of Helicobacter pylori infection

Eradication group receive Omeprazole sodium 20mg, amoxicillin 1g, clarithromycin 500mg orally at the same time twice daily for 7 days.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Sang Gyun Kim, professor · Department of Internal Medicine and Liver Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510730 on ClinicalTrials.gov